The American Association of Clinical Endocrinologists last month had a “rapid-response task force” reviewing its 2003 position paper on what it calls the “insulin resistance syndrome.”
“With the critical appraisal by the ADA, we want a well-thought-out, evidence-based response to clarify our position (on the issue),” said Jeffrey I. Mechanick, M.D., an endocrinologist who is leading the task force.